| Spike mutation D614G alters SARS-CoV-2 fitness JA Plante, Y Liu, J Liu, H Xia, BA Johnson, KG Lokugamage, X Zhang, ... Nature 592 (7852), 116-121, 2021 | 1903 | 2021 |
| Evasion of type I interferon by SARS-CoV-2 H Xia, Z Cao, X Xie, X Zhang, JYC Chen, H Wang, VD Menachery, ... Cell reports 33 (1), 2020 | 1077 | 2020 |
| Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies RE Chen, X Zhang, JB Case, ES Winkler, Y Liu, LA VanBlargan, J Liu, ... Nature medicine 27 (4), 717-726, 2021 | 1003 | 2021 |
| SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses JS Turner, JA O’Halloran, E Kalaidina, W Kim, AJ Schmitz, JQ Zhou, T Lei, ... Nature 596 (7870), 109-113, 2021 | 885 | 2021 |
| Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis BA Johnson, X Xie, AL Bailey, B Kalveram, KG Lokugamage, A Muruato, ... Nature 591 (7849), 293-299, 2021 | 766 | 2021 |
| An infectious cDNA clone of SARS-CoV-2 X Xie, A Muruato, KG Lokugamage, K Narayanan, X Zhang, J Zou, J Liu, ... Cell host & microbe 27 (5), 841-848. e3, 2020 | 733 | 2020 |
| Neutralizing activity of BNT162b2-elicited serum Y Liu, J Liu, H Xia, X Zhang, CR Fontes-Garfias, KA Swanson, H Cai, ... New England Journal of Medicine 384 (15), 1466-1468, 2021 | 697 | 2021 |
| Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera X Xie, Y Liu, J Liu, X Zhang, J Zou, CR Fontes-Garfias, H Xia, ... Nature medicine 27 (4), 620-621, 2021 | 696 | 2021 |
| The N501Y spike substitution enhances SARS-CoV-2 infection and transmission Y Liu, J Liu, KS Plante, JA Plante, X Xie, X Zhang, Z Ku, Z An, D Scharton, ... Nature 602 (7896), 294-299, 2022 | 511 | 2022 |
| Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant Y Liu, J Liu, BA Johnson, H Xia, Z Ku, C Schindewolf, SG Widen, Z An, ... Cell reports 39 (7), 2022 | 470 | 2022 |
| Low neutralization of SARS-CoV-2 Omicron BA. 2.75. 2, BQ. 1.1 and XBB. 1 by parental mRNA vaccine or a BA. 5 bivalent booster C Kurhade, J Zou, H Xia, M Liu, HC Chang, P Ren, X Xie, PY Shi Nature medicine 29 (2), 344-347, 2023 | 469 | 2023 |
| SARS-CoV-2 neutralization with BNT162b2 vaccine dose 3 AR Falsey, RW Frenck Jr, EE Walsh, N Kitchin, J Absalon, A Gurtman, ... New England Journal of Medicine 385 (17), 1627-1629, 2021 | 425 | 2021 |
| BNT162b2-elicited neutralization of B. 1.617 and other SARS-CoV-2 variants J Liu, Y Liu, H Xia, J Zou, SC Weaver, KA Swanson, H Cai, M Cutler, ... Nature 596 (7871), 273-275, 2021 | 380 | 2021 |
| A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation AE Muruato, CR Fontes-Garfias, P Ren, MA Garcia-Blanco, ... Nature communications 11 (1), 4059, 2020 | 370 | 2020 |
| An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction H Xia, H Luo, C Shan, AE Muruato, BTD Nunes, DBA Medeiros, J Zou, ... Nature communications 9 (1), 414, 2018 | 344 | 2018 |
| An infectious cDNA clone of Zika virus to study viral virulence, mosquito transmission, and antiviral inhibitors C Shan, X Xie, AE Muruato, SL Rossi, CM Roundy, SR Azar, Y Yang, ... Cell host & microbe 19 (6), 891-900, 2016 | 335 | 2016 |
| Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail J Dong, SJ Zost, AJ Greaney, TN Starr, AS Dingens, EC Chen, RE Chen, ... Nature microbiology 6 (10), 1233-1244, 2021 | 312 | 2021 |
| A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models C Shan, AE Muruato, BTD Nunes, H Luo, X Xie, DBA Medeiros, ... Nature medicine 23 (6), 763-767, 2017 | 304 | 2017 |
| Membrane topology and function of dengue virus NS2A protein X Xie, S Gayen, CB Kang, Z Yuan, PY Shi Journal of virology 87 (8), 4609-4622, 2013 | 299 | 2013 |
| Zika virus produces noncoding RNAs using a multi-pseudoknot structure that confounds a cellular exonuclease BM Akiyama, HM Laurence, AR Massey, DA Costantino, X Xie, Y Yang, ... Science 354 (6316), 1148-1152, 2016 | 287 | 2016 |
Pei-Yong ShiVP, Global Head of Viral Vaccines, GSKVerified email at utmb.edu
